Feed PBYI
PB
Puma Biotechnology, Inc.
PBYI · NASDAQ
$8.69 -2.36% (-$0.21)
1M +7.55%
Market Cap $413.3M
P/E Ratio 16.98x
Div. Yield -
ROE 20.34%
Bulios Fair Price
$5.69
34.5% downside
Preț actual
$8.69
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile PBYI sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
74 /100
Cheap P/E 16.98x
EV/EBITDA 9.56x
P/S 1.82x
Growth
63 /100
Stable EPS growth 210.89%
Rev. growth 0.05%
Book val. growth 82.03%
Profitability
80 /100
Strong Gross margin 74.43%
Net margin 10.71%
Op. margin 12.97%
Quality
98 /100
Excellent ROIC 19.97%
ROE 20.34%
ROA 12.63%
Debt
92 /100
Low Debt/Equity 0.12x
Current ratio 2.38x
Int. coverage 5.42x
Stability
56 /100
Moderate Beta 1.19x
Rev. volatility 2.89%
EPS volatility 1,211.83%
Întreabă StockBot despre PBYI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alan H. Auerbach
Employees
179
Headquarters
Los Angeles
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report